Howard (Jack) West, MD, Associate Clinical Professor, Medical Oncology, Executive Director, Employer Services, Founder, President and CEO of GRACE

Howard Jack West, MD, Founder, Board President
Twitter Feed

GRACE - Global Resource for Advancing Cancer Education

GRACE - Global Resource for Advancing Cancer Education - 4616 25th Ave NE, # 300, Seattle, Washington 98105 - Rated 4.3 based on 15 Reviews "After a...

GRACE (@cancergrace) * Instagram photos and videos

108 Followers, 115 Following, 53 Posts - See Instagram photos and videos from GRACE (@cancergrace)

H. Jack West, MD, Founder, Board President
City of Hope Comprehensive Cancer Center
Duarte
CA
Specialties
Lung Cancer

Dr. Jack West is a medical oncologist and thoracic oncology specialist, and Executive Director of Employer Services at the City of Hope Comprehensive Cancer Center in Duarte, CA. He is the Founder, and serves as President &CEO of the Global Resource for Advancing Cancer Education (GRACE) and Beacon Medical Interchange, LLC.

Dr. West received an M. Phil. in Experimental Biology from Cambridge University on a Fulbright Scholarship before returning to the US to undertake his medical training at Harvard Medical School in Boston, where he earned his MD magna cum laude and conducted research as a Howard Hughes Medical Student Fellow. He stayed in Boston for his internship and residency in internal medicine at Brigham and Women’s Hospital, then moved to Seattle, Washington for his fellowship in medical oncology at the Fred Hutchinson Cancer Research Center/University of Washington. He moved to the Swedish Cancer Institute in Seattle in late 2002, where he directed the medical oncology component of thoracic oncology program. He moved to City of Hope in March, 2019 to build programs to export subspecialty insights to patients across a broad geography.

Dr. West maintains a strong clinical research focus on lung cancer and has authored dozens of peer-reviewed as well as invited publications. He also serves as Web Editor for JAMA Oncology and a section editor and author for the lung cancer section of UpToDate.  Finally, he continues to develop a wide range of novel educational content across many platforms for other physicians, patients, and caregivers through GRACE, Beacon Medical Interchange, and Medscape.


So What's New in Cancer Care?

Beacon Medical Interchange is a venture founded in 2016 by Dr. Jack West to facilitate communication of medical experts with industry leaders on the evolution of medical care trends in general and cancer management in particular.

Dr. David Spigel, Part 1: Clinical Research, Community Care (BMIC-074) - BeaconMedIC

Dr. Jack West interviews Dr. David Spigel of Sarah Cannon Research Institute on the challenges of conducting clinical trials and delivering increasingly complex patient care, along with the possible future role of artificial intelligence and telemedicine. (24:32)  Download MP3 Audio Version

Conflict of Interest

President and Founder of OncTalk, LLC (intellectual property transferred to GRACE)
Consultant – AstraZeneca, Eli Lilly, Genentech, GenMab, OSI Pharmaceuticals sanofi-aventis; Center for Biomedical Continuing Education
Speakers Bureau – Eli Lilly, Genentech

The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging information in targeted therapies, and answering patient questions in real-time.

In this video series, GRACE Board Members Dr. H. Jack West, Dr. Jared Weiss, and Dr. Ben Levy have continued candid discussions regarding cancer and COVID-19.

In this continued time of social distancing and limiting clinic exposure, the doctors sat down to virtually discuss some of the questions we all hear regarding these unprecedented times, and how they affect primarily cancer patients.

In this video, the discussion is surrounding the variable acceptance of the COVID19 vaccine. 

Drs. H. Jack West, Joan Schiller, and Isabel Preeshagul gathered this past year (virtually) to review information presented at ASCO and ESMO 2021, regarding patients dealing with a Lung Cancer diagnosis.

For this series, the doctors discuss new trials for patients with NSCLC and SCLC.  The video discussions cover the following topics:

Drs. H. Jack West, Joan Schiller, and Isabel Preeshagul gathered (virtually)  to review information presented at ASCO and ESMO for 2021.  

For this series, the doctors discuss new trials for patients with NSCLC. In this video, the doctors discuss IMpower010, and Adjuvant Atezolizumab After Chemotherapy in Resected Stage I-IIIA NSCLC.  
 

Forum Discussions

Original post date: 2015-03-30

Just wanted to give a heads up to people who may be interested that the newest Ken Burns documentary is on the Story of Cancer, and it starts tonight. It'll be running on PBS over 3 nights.

You can

Last Activity: Fri, 03/29/2019 - 00:22
Original post date: 2014-12-31

Dear all,

We don't do pop-ups or send lots of messages asking for support, but we do depend on your support to continue to offer our services at no cost. I do everything I do for GRACE with no pay

Last Activity: Fri, 03/29/2019 - 00:22
Original post date: 2014-12-24

I just wanted to wish everyone who celebrates it a Merry Christmas!

-Dr. West

Last Activity: Fri, 03/29/2019 - 00:37
Original post date: 2014-10-31

"CraigInPA" is our beloved and amazingly knowledgeable friend with a ROS1 rearrangement, who is a living testament to how insightful patients can become. He also highlights how patient communities can

Last Activity: Fri, 03/29/2019 - 00:22
Original post date: 2014-09-26

Immunotherapy is causing an incredible buzz in the cancer world, so learn more about it in the setting of kidney cancer, melanoma, and lung cancer by coming to our patient forum with the leading

Last Activity: Fri, 03/29/2019 - 00:36

Comments

Post Date: 2022-03-30

AbbyAnnie,

It's worth highlighting what is known and what is still unknown here. The role of the

Post Date: 2022-03-12
Original Post: T790M finally detected

JojoS,

It is important to note that no test is perfectly sensitive at detecting a target all the

Post Date: 2022-01-07

John,

I'm sorry to hear about what your wife and you have been going through. This sounds

Post Date: 2021-12-02

Carole,

These approaches haven't been directly compared, and it really depends on who can do the

Post Date: 2020-12-03

Essentially, I would say that people shouldn't be duped by the GioTag "study". It was an analysis